Researcher

Dr Alvin Kamili

Keywords

Biography

Dr Alvin Kamili is a senior research officer and preclinical drug testing core team coordinator in the Zero Childhood Cancer - Personalised Medicine Program at the Children’s Cancer Institute, Sydney, Australia. He mainly focuses on the establishment of preclinical models for neuroblastoma, a disease in which patients frequently relapse with incurable, drug resistant disease, resulting in long-term survival rates below 50%. His works aim to...view more

Dr Alvin Kamili is a senior research officer and preclinical drug testing core team coordinator in the Zero Childhood Cancer - Personalised Medicine Program at the Children’s Cancer Institute, Sydney, Australia. He mainly focuses on the establishment of preclinical models for neuroblastoma, a disease in which patients frequently relapse with incurable, drug resistant disease, resulting in long-term survival rates below 50%. His works aim to implement personalised medicine approach to improve patient survival rates through identifying molecular aberration underlying cancer progression in individual patient, screening ex vivo tumour cells against library of anticancer drugs, and developing improved pre-clinical testing models.


My Grants

NHMRC Ideas Grant, 2020-2021, $286,900, Improving induction therapy for high-risk neuroblastoma through bypass or inhibition of P-glycoprotein (APP1182974) 


My Qualifications

Bachelor of Medical Science (Hons I), UNSW Sydney

PhD, University of Sydney


My Research Supervision


Supervision keywords


Areas of supervision

  • Modelling personalised medicine strategies in high-risk neuroblastoma
  • Preclinical testing of anticancer drugs for high-risk neuroblastoma
View less

Location

Children's Cancer Institute
Level 1, Lowy Cancer Research Centre
The University of New South Wales, Sydney, NSW 2052, Australia